INTRODUCTION
Cholesterol biosynthesis in mammalian cells is regulated by the enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase [1] . An endoplasmic-reticulum-membrane-associated protein with a monomeric weight of 97 kDa [2, 3] , HMG-CoA reductase is responsible for the production of mevalonate, a precursor of cholesterol as well as non-sterol isoprenoids such as ubiquinone, dolichol and isopentenyl-tRNA [4] . Both cholesterol and mevalonate are required for the inhibition of reductase in mammalian cells; inhibition occurs at the transcriptional [2, 3, [5] [6] [7] [8] [9] [10] , posttranscriptional [11] [12] [13] [14] [15] and post-translational levels [16] [17] [18] . When both cholesterol (or an oxysterol such 25-hydroxycholesterol) and mevalonate are provided exogenously to mammalian cells, reductase levels decrease rapidly. This is due to a 2-4-fold reduction in HMG-CoA reductase mRNA levels, a 30-90-fold reduction in translation and a 2-3-fold increase in degradation of the enzyme [6, 7, 11, 13, 14, 19] .
We recently found that inhibition of protein synthesis with cycloheximide blocked oxysterol-mediated reduction of reductase mRNA in baby hamster kidney (BHK) cells. When 25-hydroxycholesterol and cycloheximide were added simultaneously to cells treated with lovastatin, a competitive inhibitor of HMGCoA reductase, reductase mRNA levels were not reduced relative to cells treated only with lovastatin [20] . In addition, when cycloheximide was added to cells grown in medium supplemented with serum, conditions under which reductase mRNA levels are equal to those in cells treated with 25-hydroxycholesterol, suppression of reductase mRNA was blocked, and mRNA levels increased approx. 10-fold within 5 h. As determined by run-on assays, in neither case did we find that cycloheximide treatment presence of lovastatin and an oxysterol, 25-hydroxycholesterol, /-globin RNA levels were decreased approx. 2-fold. Inhibition of protein synthesis with cycloheximide blocked the effects of 25- hydroxycholesterol on ,J-globin RNA. Moreover We then excised the 4600 bp BamHI-HincII fragment containing full-length cDNA for hamster reductase from pRed227 [26] and cloned it into the BamHI-SmaI restriction sites ofp/JGlo to create p,/Glo/Red-l. Except for 1416 bp of the untranslated region, all reductase sequences were removed from p,/Glo/Red-1 by BamHI-BglII digestion, and the plasmid was religated to create pflGlo/Red-2_ The remaining reductase untranslated region contained two polyadenylation sites used endogenously in hamster cells [27] .
The BglII-XbaI fragment of vector pCAT-Control (Promega) was isolated and cloned into the BamHI-XbaI cloning site of pGEM7Z + to create pGEM/CAT. This fragment contained the SV40 promoter, bacterial chloramphenicol acetyltransferase (CAT) gene, and SV40 enhancer sequences. CAT CsCl gradient centrifugation, as described previously [23] . Medium was removed from each plate, 3 ml of calcium phosphate/ DNA suspension was added, and the incubation continued for 15 min at room temperature. Cells were subsequently refed with fresh FBS/MEM, incubated for 24 h, then treated with trypsin and divided into four equal portions on 90 mm plates. They were maintained in FBS/MEM for 24 h, after which the medium was changed to DFBS/MEM and 25 ,M lovastatin. After 16 h of incubation, either 25-hydroxycholesterol alone (1.2,M) or 25-hydroxycholesterol (1.2 #M) plus cycloheximide (10 mg/ml) was added to the medium; cells were incubated for an additional 4 h and lysed in 4 M guanidinium isothiocyanate. Both /J-globin and S17 ribosomal protein RNA levels were then measured by the RNAase-protection assay.
Preparation of riboprobes Riboprobes used to measure /3-globin RNA in transfected cells were generated from plasmid p,fGlo/Red-1 linearized with PvuII.
Riboprobes for S17 ribosomal RNA protein were synthesized from pRPS17 digested with Avall. Both antisense probes were synthesized using T7 RNA polymerase according to the conditions of Melton et al. [29] .
Lysate RNAase-protection assay RNAase-protection assays were performed as described by Haines and Gillespie [30] with minor modifications. Cells (2 x I07) were dissolved in 5 M guanidinium isothiocyanate/0. 1 M EDTA. To control for RNA-loading differences, levels of hamster ribosomal protein S17 RNA were also determined. S17 is a constitutively expressed protein, and its mRNA has been shown to remain unchanged in other studies using similar conditions [19] . Cell lysate (20 Precipitated riboprobes were dissolved in RNA sample loading buffer and electrophoresed on 6-80% polyacrylamide (acrylamide/bisacrylamide, 38:2)/7 M urea gels at 250 V. The resultant gel was exposed to X-ray film (Kodak) for an appropriate period at -70 'C.
RESULTS
To determine whether the oxysterol-regulated degradation of HMG-CoA reductase mRNA reported previously [20] involves an instability element, pfiGlo/3'UT, a fusion gene that has both the human 8-globin gene and the 3'-untranslated region of hamster HMG-CoA reductase cDNA (Figure la) , was transfected into CHO cells. Although the cycloheximide-mediated block to oxysterol-dependent suppression of HMG-CoA reductase mRNA was originally observed in BHK C100 cells, we chose to transfect CHO cells with fl-globin fusion constructs because the transfection frequencies were consistently higher in these cells than in BHK cells. In addition, regulation of HMGCoA reductase in the two cell lines has been demonstrated to be identical [3, 5] . /3-Globin mRNA is a convenient reporter gene because it is not expressed in this fibroblastic cell type (Figure 2a , control lane) and does not contain any of the sequence elements required for sterol-mediated regulation [10, 19] . Initially, transfected cells were treated with either FBS/MEM alone or DFBS/MEM plus lovastatin, a competitive inhibitor of reductase [31] that increases cellular reductase mRNA levels through transcriptional mechanisms [19] . When 32P-labelled antisense 8-globin RNA was hybridized to lysates prepared from these cells, 196-and 145-base RNA fragments were observed (Figure 2a, lanes 1 and 2) Table 2 . Ribosomal protein S-1 7 mRNA levels were determined for each lysate and these values were used to correct for variation in RNA loading (results not shown).
and 25-hydroxycholesterol was also measured (Figure 2a, lane  3) . The oxysterol, 25-hydroxycholesterol, is a potent suppressor of reductase mRNA in lovastatin-treated cells [11, 20, 32] and has been shown to mediate its effects at the transcriptional level through the sterol-response element in the 5' promoter region of the reductase gene [10, 19] 25 -hydroxycholesterol regulates expression of the fusion construct through a post-transcriptional mechanism that involves the 3'-untranslated region of reductase. Cells were also treated with 25-hydroxycholesterol in the absence of lovastatin and these results are summarized in Figure  3 and Table 2 . In cells treated with DFBS/MEM plus 25- We then investigated the role of protein synthesis in oxysterolmediated suppression of/I-globin mRNA by exposing transfected cells to both 25-hydroxycholesterol and the protein synthesis inhibitor cycloheximide (Figure 2a, lane 4) . Under such conditions, /3-globin RNA levels were not suppressed compared with those in cells treated with 25-hydroxycholesterol (lane 3); rather they were elevated 5-fold (Table 1 ). In addition, /3-globin RNA levels were increased by approx. 2-fold compared with lovastatinonly treatment ( Figure 2a, lane 2 ; Table 1 ). An increase in figlobin RNA levels of similar magnitude was observed in cells treated with lovastatin in the absence of 25-hydroxycholesterol ( Figure 3a , lane 4; Table 2 ). These results are analogous to those reported previously in which cycloheximide stabilized cellular reductase transcripts and blocked oxysterol-mediated suppression of HMG-CoA reductase mRNA [20] . Apparently, the 3'-untranslated region of HMG-CoA reductase mRNA increases the stability of the f-globin transcript when protein synthesis is inhibited with cycloheximide.
To confirm that HMG-CoA reductase 3'-untranslated sequences of p/?Glo/3'UT were specifically required for posttranscriptional regulation by 25-hydroxycholesterol, we transfected cells with pfiGlo/SV40 (Figure lb) in which reductase sequences were replaced with SV40 enhancer sequences. When corrected for loading differences by scanning the S17 ribosomal protein RNA band, no appreciable difference in /3-globin levels was observed under the same conditions as used above ( Figure  2b ; Table 1 Other studies have demonstrated the importance of 3'-untranslated sequences in regulating various genes [37] [38] [39] [40] . When fused with /3-globin-coding sequences and expressed in cells, 3'-untranslated sequences impart to /,-globin RNA regulatory control that is characteristic of the heterologous mRNA. For example, transcripts for c-fos and lymphokine granulocytemonocyte colony-stimulating factor (GM-CSF) are degraded more rapidly than /8-globin mRNA [38] [39] [40] . However, when 3'-untranslated sequences of either c-fos [38, 39] or GM-CSF cDNA [40] are fused to ,8-globin cDNA-coding sequences, mRNA from the /,-globin fusion construct decays with kinetics characteristic of c-fos and GM-CSF mRNA, i.e. more rapidly than 8-globin mRNA itself. The motif responsible for this rapid degradation is AUUA, located in the 3'-untranslated regions of c-fos and GM-CSF mRNA [40, 41] as well as other mRNAs with short half-lives [37] .
In the case of reductase mRNA, the 3'-untranslated region of the mRNA contains AUUUA motifs characteristic of unstable mRNAs [42] . However, their role in oxysterol-mediated posttranscriptional control of reductase mRNA, as well as their stabilization by cycloheximide, has not yet been established. Post-transcriptional control of reductase by oxysterols may function in one of two ways. Oxysterols may enhance the activity of a specific nuclease or group of nucleases that recognize specific motifs or secondary structure in 3'-untranslated reductase sequences. Alternatively, they may reduce the affinity of a specific mRNA-binding protein that protects reductase mRNA from degradation. Proteins binding to AUUUA [43] and other semRNAs have been identified. However, their role in degradation or stabilization of mRNA has not been demonstrated. Results from studies in this laboratory in which cycloheximide blocked oxysterol-mediated reduction in reductase mRNA [20] have suggested that a labile protein is involved in the post-transcriptional process. This was confirmed here with the /3-globin fusion construct. Current experiments are directed toward identifying not only specific sequences in the 3'-untranslated 1416 bp region that control oxysterol regulation of reductase but also proteins that interact with these regions. This work was supported by Public Health Service Grant HL44006 (to D. M. P.). We thank Dr. Patricia Hentosh for critical reading of the manuscript.
